- Home
- AUPH vs HTH Comparison
AUPH vs HTH Comparison
Compare AUPH & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUPH | HTH |
|---|---|---|
| Founded | 1993 | 1998 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 2014 | 2003 |
Fundamental Metrics
Financial Performance| Metric | AUPH | HTH |
|---|---|---|
| Price | $16.29 | $38.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | $17.25 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 1.2M | 197.6K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | ★ 5075.00 | 51.72 |
| EPS | 0.53 | ★ 1.27 |
| Revenue | ★ $283,055,000.00 | $152,188,000.00 |
| Revenue This Year | $17.54 | N/A |
| Revenue Next Year | $15.74 | $3.22 |
| P/E Ratio | $31.08 | ★ $30.37 |
| Revenue Growth | ★ 20.38 | 15.52 |
| 52 Week Low | $10.34 | $30.78 |
| 52 Week High | $19.25 | $40.41 |
Technical Indicators
Market Signals| Indicator | AUPH | HTH |
|---|---|---|
| Relative Strength Index (RSI) | 54.99 | 46.64 |
| Support Level | $14.61 | $38.34 |
| Resistance Level | $16.46 | $40.03 |
| Average True Range (ATR) | 0.48 | 0.57 |
| MACD | 0.10 | -0.09 |
| Stochastic Oscillator | 50.68 | 28.04 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The company has three segments: The banking segment includes the operations of the Bank; The broker-dealer segment includes the operations of Securities Holdings,; and the mortgage origination segment is composed of PrimeLending. Majority of revenue is from Broker-dealer Segment.